Association of genetic polymorphisms in CYP1A1 and NAT2 with susceptibility to renal cancer: A case control study

Academic Journal of Second Military Medical University

Volumn 29, Issue 10, 2008, Pages 1147-1152

  Wang, Guo Ping ^a   Zhang, Peng ^a   Xu, Min ^a   Chang, Wen Jun ^a   Liu, Shi Jian ^a   Zhang, Hong Wei ^a   Cao, Guang Wen ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cytochrome P 450 1A1; Genetic susceptibility; N acetyltransferase 2; Polymorphism; Renal cancer

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; CYTOCHROME P450 1A1;

ARTICLE; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; KIDNEY CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR;

EID: 55049096745     PISSN: 0258879X     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1008.2008.01147     Document Type: Article

References (30)

1. Chinese source.
2. Hein D W,Doll M A,Fretland A J,Leff M A, Webb S J,Xiao G H, et al. Molecular genetics and epidemiology of the NATI and NAT2 acetylation polymorphisms[J]. Cancer Epidemiol Biomarkers Prev,2000,9:29-42.
3. Chinese source.
4. Chinese source.
5. Raaumio H, Husgafvel-Pursiainen K, Anttila S, Hietanen E, Hirvonen A, Pelkonen O. Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility-a review[J]. Gene, 1995,159:113-121.
6. Smith G B,Harper P A,Wong J M,Lam M S,Reid K R,Petsikas D, et al. Human lung microsomal cytochrome P4501A1 (CYPIA1) activities:impact of smoking status and CYP1A1, aryl hydrocarbon receptor, and glutathione S-transferase M1 genetic polymorphisms[J]. Cancer Epidemiol Biomarkers Prev, 2001,10:839-853.
7. Longuemaux S,Deloménie C,Gallou C,Méjean A,Vincent-Viry M, Bouvier R, et al. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes[J]. Cancer Res,1999, 59:2903-2908.
8. Cascorbi I,Brockmöller J,Roots I. A C4887A Polymorphism in exon 7 of human CYP1A1: polulation frequency,mutation linkages, and lung cancer susceptibility[J]. Cancer Res, 1996, 56: 4965-4969.
9. Pandey S N, Choudhuri G, Mittal B. Association of CYP1A1 Msp1 polymorphism with tobacco-related risk of gallbladder cancer in a north Indian population[J]. Eur J Cancer Prev, 2008,17:77-81.
10. Mittal R D, Srivastava D L. Cytochrome P4501A1 and microsomal epoxide hydrolase gene polymorphisms: gene-environment interaction and risk of prostate cancer[J]. DNA Cell Biol, 2007,26:791-798.
11. Shah P P,Singh A P,Singh M,Mathur N,Pant M C,Mishra B N, et al. Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer[J]. Mutat Res,2008,639:1-10.
12. Gallegos-Arreola M P,González-García J R,Figuera L E,Puebla-Pérez A M, Delgado-Lamas J L,Zúniga-González G M. Distribution of CYP1A12A polymorphism in adult patients with acute lymphoblastic leukemia in a Mexican population[J]. Blood Cells Mol Dis,2008,41:91-94.
13. Juárez-Cedillo T, Vallejo M, Fragoso J M, Hernández-Hernández D M, Rodríguez-Pérez J M,Sánchez-García S,et al. The risk of developing cervical cancer in Mexican women is associated to CYP1A1 Msp I polymorphism[J]. Eur J Cancer, 2007,43:1590-1595.
14. Zhang X M,Xu G,Shan J,Jin G D,Huang C L,Wu K S. Association of the Msp I polymorphism of cytochrome P4501A1 gene and smoking to the susceptibility to coronary artery disease[J]. Zhonghua Xin Xue Guan Bing Za Zhi,2007,35:536-539. 15 Hirata H,Hinoda Y, Okayama N, Suehiro Y, Kawamoto K, Kikuno N,et al. CYP1A1,SULT1A1,and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibility [J]. Cancer,2008.
15. Kang S H,Kim T Y,Kim H Y, Yoon J H,Cho H I,Yoon S S, et al. Protective role of CYP1A1 * 2A in the development of multiple myeloma[J]. Acta Haematol,2008,119:60-64.
16. Wang X,Zhang L,Ou R,Wang J,Liu S,Chen Q,et al. Association between CYP1A1 gene polymorphism and intrahepatic cholestasis of pregnancy[J]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi,2008,25:70-72.
17. Srivastava D S, Mandhani A, Mittal R D. Genetic polymorphisms of cytochrome P450 CYP1A1 (* 2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India[J]. Arch Toxicol,2008.
18. Agorastos T,Papadopoulos N,Lambropoulos A F,Chrisafi S, Mikos T,Goulis D G,et al. Glutathione-S-transferase M1 and T1 and cytochrome P1A1 genetic polymorphisms and susceptibility to cervical intraepithelial neoplasia in Greek women[J]. Eur J Cancer Prev,2007,16:498-504.
19. Fretland A J,Leff M A,Doll M A,Hein D W. Functional characterization of human N-acetyltransferase 2 single nucleotide polymorphisms[J]. Pharmacogenetics,2001,11:207-215.
20. Boccia S,Sayed-Tabatabaei F A,Persiani R,Gianfagna F,Rausei S, Arzani D, et al. Polymorphisms in metabolic genes, their combination and interaction with tobacco smoke and alcohol consumption and risk of gastric cancer: a case-control study in an Italian population[J]. BMC Cancer,2007,7:206.
21. Tsukino H,Omori H,Kohshi K,Yamano Y,Katoh T. Molecular epidemiology and urothelial cancerLJ]. J UOEH,2007,29: 265-289.
22. Cho H J,Koh W J,Ryu Y J,Ki C S,Nam M H,Kim J W,et al. Genetic polymorphisms of NAT2 and CYP2E1 associated with antituberculosis drug-induced hepatotoxicity in Korean patients with pulmonary tuberculosis[J]. Tuberculosis (Edinb),2007, 87:551-556.
23. Murta-Nascimento C,Silverman D T,Kogevinas M,García-Closas M, Rothman N,Tardón A, et al. Risk of bladder cancer associated with family history of cancer: do low-penetrance polymorphisms account for the increase in risk[J]. Cancer Epidemiol Biomarkers Prev,2007,16:1595-1600.
24. Egeberg R,Olsen A,Autrup H,Christensen J,Stripp C,Tetens I, et al. Meat consumption, N-acetyl transferase 1 and 2 polymorphism and risk of breast cancer in Danish postmenopausal women[J]. Eur J Cancer Prev,2008,17:39-47.
25. Osawa Y,Osawa K K,Miyaishi A,Higuchi M,Tsutou A,Matsumura S, et al. NAT2 and CYP1A2 polymorphisms and lung cancer risk in relation to smoking status[J]. Asian Pac J Cancer Prev,2007,8:103-108.
26. Jain M,Kumar S,Lal P,Tiwari A,Ghoshal U C,Mittal B. Association of genetic polymorphisms of N-acetyltransferase 2 and susceptibility to esophageal cancer in north Indian population [J]. Cancer Invest,2007,25:340-346.
27. Hooker S, Bonilla C, Akereyeni F, Ahaghotu C, Kittles R A. NAT2 and NER genetic variants and sporadic pros cancer susceptibility in African Americans[J]. Prostate Cancer Prostatic Dis,2007.
28. Al-Moundhri M S, Al-Kindi M, Al-Nabhani M, Al-Bahrani B, Burney I A,Al-Madhani A, et al. NAT2 polymorphism in Omani gastric cancer patients-risk predisposition and clinicopathological associations[J]. World J Gastroenterol, 2007, 13: 2697-2702.
29. Huang C C,Chien W P,Wong R H,Cheng Y W,Chen M C, Chou M C, et al. NAT2 fast acetylator genotype is associated with an increased risk of colorectal cancer in Taiwan[J]. Dis Colon Rectum,2007,50:981-989.
30. Wiencke J K,Thurston S W,Kelsey K T,Varkonyi A,Wain J C, Mark E J,et al. Early age at smoking initiation and tobacco carcinogen DNA damage in the lung[J]. J Natl Cancer Inst, 1999,91:614-619.